{"schema_version":"1","generated_at":"2026-11-20T16:34:45.602Z","data_as_of":null,"url":"https://www.findmykol.com/kol/prashanth-sunkureddi","json_url":"https://www.findmykol.com/kol/prashanth-sunkureddi/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"prashanth-sunkureddi","name":"Prashanth Sunkureddi","credential":"MD","specialty":"Rheumatology","specialty_raw":"Rheumatology","therapeutic_area":"Rheumatology/Immunology","therapeutic_areas":["Rheumatology/Immunology"],"institution":"The University of Texas Medical Branch at Galveston","institution_url":"https://www.findmykol.com/institution/the-university-of-texas-medical-branch-at-galveston","city":"League City","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"on_file":["npi","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Prashanth Sunkureddi is a Rheumatology/Immunology physician affiliated with The University of Texas Medical Branch at Galveston. OpenAlex indexes 23 publications with 815 citations (h-index 9).","overview":null,"focus":{"indications":[],"research_topics":["Rheumatology/Immunology"]},"scholarship":{"works_count":23,"cited_by_count":815,"h_index":9,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":41,"program_years":{"first":2021,"last":null},"rows_total":124,"shown":3,"withheld":121,"rows":[{"payer":"ABBVIE INC.","program_year":2025,"amount_usd":1058.68,"payment_count":44},{"payer":"Amgen Inc.","program_year":2025,"amount_usd":717.61,"payment_count":30},{"payer":"UCB, Inc.","program_year":2025,"amount_usd":708.74,"payment_count":15}],"source":"payments"},"prescribing":{"data_year":2023,"areas_total":8,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":95.8,"classes_total":9,"classes":[{"class":"TNF inhibitor","setting":"mixed","share_pct":62.5,"drugs":[{"name":"Certolizumab pegol","share_pct":87.2},{"name":"Golimumab","share_pct":12.7},{"name":"Enbrel Sureclick","share_pct":0},{"name":"Humira(Cf) Pen","share_pct":0},{"name":"Enbrel Mini","share_pct":0}],"max_beneficiaries":null},{"class":"Interleukin-6 Receptor Antagonist","setting":"administered","share_pct":20.5,"drugs":[{"name":"Tocilizumab","share_pct":100}],"max_beneficiaries":13}]},{"area":"Musculoskeletal","share_pct":3.6,"classes_total":6,"classes":[{"class":"RANK Ligand Inhibitor","setting":"mixed","share_pct":3.5,"drugs":[{"name":"Denosumab","share_pct":98.9},{"name":"Prolia","share_pct":1.1}],"max_beneficiaries":63},{"class":"Bisphosphonate","setting":"administered","share_pct":0.1,"drugs":[{"name":"Zoledronic acid","share_pct":100}],"max_beneficiaries":34}]},{"area":"Metabolism & gastrointestinal","share_pct":0.2,"classes_total":4,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":0.1,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":59},{"class":"Antidiarrheal microorganisms","setting":"prescribed","share_pct":0,"drugs":[{"name":"Folic Acid","share_pct":100}],"max_beneficiaries":13}]}],"care_setting":{"dominant":"office","data_year":2023,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":23,"shown":5,"withheld":18,"matched_by":"OpenAlex author record","recent":[{"title":"Characteristics of Patients with Psoriatic Arthritis Receiving Secukinumab and Reasons for Initiation: A US Retrospective Medical Chart Review","year":2019,"journal":"Rheumatology and Therapy","source_url":"https://doi.org/10.1007/s40744-018-0137-z","status":"verified"},{"title":"Characterization of Patients with Ankylosing Spondylitis Receiving Secukinumab and Reasons for Initiating Treatment: A US Physician Survey and Retrospective Medical Chart Review","year":2019,"journal":"Drugs - Real World Outcomes","source_url":"https://doi.org/10.1007/s40801-018-0146-9","status":"verified"},{"title":"FRI0426 IXEKIZUMAB MAKES REMISSION AND LOW DISEASE ACTIVITY POSSIBLE IN PATIENTS WITH PSORIATIC ARTHRITIS: TWO-YEAR RESULTS IN TNF INADEQUATE RESPONDERS OR BIOLOGIC-NAïVE PATIENTS","year":2019,"journal":"Annals of the Rheumatic Diseases","source_url":"https://doi.org/10.1136/annrheumdis-2019-eular.1225","status":"verified"},{"title":"Evaluation of Self-reported Patient Experiences: Insights from Digital Patient Communities in Psoriatic Arthritis","year":2018,"journal":"The Journal of Rheumatology","source_url":"https://doi.org/10.3899/jrheum.170500","status":"verified"},{"title":"Using Self-Reported Patient Experiences to Understand Patient Burden: Learnings from Digital Patient Communities in Ankylosing Spondylitis","year":2018,"journal":"Advances in Therapy","source_url":"https://doi.org/10.1007/s12325-018-0669-1","status":"verified"}],"source":"works"},"similar":[{"name":"Antonio Bianco","slug":"antonio-bianco","institution":"The University of Texas Medical Branch at Galveston","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/antonio-bianco","json_url":"https://www.findmykol.com/kol/antonio-bianco/profile.json"},{"name":"William Calhoun","slug":"william-calhoun","institution":"The University of Texas Medical Branch at Galveston","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/william-calhoun","json_url":"https://www.findmykol.com/kol/william-calhoun/profile.json"},{"name":"Peter Kan","slug":"peter-kan","institution":"The University of Texas Medical Branch at Galveston","specialty":"Neurological Surgery","url":"https://www.findmykol.com/kol/peter-kan","json_url":"https://www.findmykol.com/kol/peter-kan/profile.json"},{"name":"Shawn Nishi","slug":"shawn-nishi","institution":"The University of Texas Medical Branch at Galveston","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/shawn-nishi","json_url":"https://www.findmykol.com/kol/shawn-nishi/profile.json"},{"name":"David Felson","slug":"david-felson","institution":"Boston University","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/david-felson","json_url":"https://www.findmykol.com/kol/david-felson/profile.json"},{"name":"Marc Hochberg","slug":"marc-hochberg","institution":"University of Maryland School of Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/marc-hochberg","json_url":"https://www.findmykol.com/kol/marc-hochberg/profile.json"},{"name":"Philip Mease","slug":"philip-mease","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/philip-mease","json_url":"https://www.findmykol.com/kol/philip-mease/profile.json"},{"name":"Michelle Petri","slug":"michelle-petri","institution":"Johns Hopkins University School of Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/michelle-petri","json_url":"https://www.findmykol.com/kol/michelle-petri/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":121,"publications":18}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}